{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:06:36Z","timestamp":1787429196129,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1007\/s00228-019-02674-5","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T17:57:19Z","timestamp":1554919039000},"page":"1143-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatotoxicity risk factors and acetaminophen dose adjustment, do prescribers give this issue adequate consideration? A French university hospital study"],"prefix":"10.1007","volume":"75","author":[{"given":"Astrid","family":"Bacle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Pronier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Gilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Polard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Potin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-9107","authenticated-orcid":false,"given":"Lucie-Marie","family":"Scailteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","volume":"55","author":"DD Gummin","year":"2017","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W (2017) 2016 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila) 55:1072\u20131252. https:\/\/doi.org\/10.1080\/15563650.2017.1388087","journal-title":"Clin Toxicol (Phila)"},{"key":"2674_CR2","doi-asserted-by":"publisher","unstructured":"Guerlais M et al (2018) Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12-14 June 2018, Toulouse, France \u201cMisuse of analgesics in the context of self-medication: resutls of a large cross-sectional survey from the DANTE study (une D\u00e9cennie d\u2019ANTalgiques en France) (CO-041). Fundam Clin Pharmacol 32:16. https:\/\/doi.org\/10.1111\/fcp.12370","DOI":"10.1111\/fcp.12370"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","volume":"376","author":"W Bernal","year":"2010","unstructured":"Bernal W, Auzinger G, Dhawan A, Wendon J (2010) Acute liver failure. Lancet 376:190\u2013201","journal-title":"Lancet"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"f403","DOI":"10.1136\/bmj.f403","volume":"346","author":"K Hawton","year":"2013","unstructured":"Hawton K, Bergen H, Simkin S, Dodd S, Pocock P, Bernal W, Gunnell D, Kapur N (2013) Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses. BMJ 346:f403","journal-title":"BMJ"},{"key":"2674_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bcp.12635","volume":"80","author":"SE Gulmez","year":"2015","unstructured":"Gulmez SE, Larrey D, Pageaux G-P, Bernuau J, Bissoli F, Horsmans Y, Thorburn D, McCormick PA, Stricker B, Toussi M, Lignot-Maleyran S, Micon S, Hamoud F, Lassalle R, Jov\u00e9 J, Blin P, Moore N (2015) Liver transplant associated with paracetamol overdose: results from the seven-country SALT study. Br J Clin Pharmacol 80:599\u2013606","journal-title":"Br J Clin Pharmacol"},{"key":"2674_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(95)91385-8","volume":"346","author":"JA Vale","year":"1995","unstructured":"Vale JA, Proudfoot AT (1995) Paracetamol (acetaminophen) poisoning. Lancet 346:547\u2013552","journal-title":"Lancet"},{"key":"2674_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bcp.12604","volume":"80","author":"DN Bateman","year":"2015","unstructured":"Bateman DN (2015) Paracetamol poisoning: beyond the nomogram. Br J Clin Pharmacol 80:45\u201350","journal-title":"Br J Clin Pharmacol"},{"key":"2674_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/15563650.2012.659252","volume":"50","author":"BH Rumack","year":"2012","unstructured":"Rumack BH, Bateman DN (2012) Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila) 50:91\u201398","journal-title":"Clin Toxicol (Phila)"},{"key":"2674_CR9","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jhep.2017.07.005","volume":"67","author":"WM Lee","year":"2017","unstructured":"Lee WM (2017) Acetaminophen (APAP) hepatotoxicity-Isn\u2019t it time for APAP to go away? J Hepatol 67:1324\u20131331","journal-title":"J Hepatol"},{"key":"2674_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jpainsymman.2013.08.001","volume":"46","author":"R Twycross","year":"2013","unstructured":"Twycross R, Pace V, Mihalyo M, Wilcock A (2013) Acetaminophen (paracetamol). J Pain Symptom Manag 46:747\u2013755","journal-title":"J Pain Symptom Manag"},{"key":"2674_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00228-017-2356-6","volume":"74","author":"TM Caparrotta","year":"2018","unstructured":"Caparrotta TM, Antoine DJ, Dear JW (2018) Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature. Eur J Clin Pharmacol 74:147\u2013160","journal-title":"Eur J Clin Pharmacol"},{"key":"2674_CR12","doi-asserted-by":"publisher","unstructured":"(2018) What dose of paracetamol for older people? Drug Ther Bull 56:69\u201372. https:\/\/doi.org\/10.1136\/dtb.2018.6.0636","DOI":"10.1136\/dtb.2018.6.0636"},{"issue":"Suppl 1","key":"2674_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11739-011-0688-2","volume":"6","author":"FP Schena","year":"2011","unstructured":"Schena FP (2011) Management of patients with chronic kidney disease. Intern Emerg Med 6(Suppl 1):77\u201383","journal-title":"Intern Emerg Med"},{"key":"2674_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0272-6386(96)90561-2","volume":"28","author":"RC Blantz","year":"1996","unstructured":"Blantz RC (1996) Acetaminophen: acute and chronic effects on renal function. Am J Kidney Dis 28:S3\u2013S6","journal-title":"Am J Kidney Dis"},{"key":"2674_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0399-8320(06)73309-7","volume":"30","author":"D Larrey","year":"2006","unstructured":"Larrey D (2006) Is there a risk to prescribe paracetamol at therapeutic doses in patients with acute or chronic liver disease? Gastroenterol Clin Biol 30:753\u2013755","journal-title":"Gastroenterol Clin Biol"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cld.2013.07.005","volume":"17","author":"C Bunchorntavakul","year":"2013","unstructured":"Bunchorntavakul C, Reddy KR (2013) Acetaminophen-related hepatotoxicity. Clin Liver Dis 17:587\u2013607 viii","journal-title":"Clin Liver Dis"},{"key":"2674_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1046\/j.1365-2796.2003.01097.x","volume":"253","author":"J Kurtovic","year":"2003","unstructured":"Kurtovic J, Riordan SM (2003) Paracetamol-induced hepatotoxicity at recommended dosage. J Intern Med 253:240\u2013243","journal-title":"J Intern Med"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2796.1992.tb00976.x","volume":"231","author":"LS Eriksson","year":"1992","unstructured":"Eriksson LS, Broom\u00e9 U, Kalin M, Lindholm M (1992) Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med 231:567\u2013570","journal-title":"J Intern Med"},{"key":"2674_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000111032","volume":"75","author":"S Kr\u00e4henbuhl","year":"2007","unstructured":"Kr\u00e4henbuhl S, Brauchli Y, Kummer O et al (2007) Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage. Digestion 75:232\u2013237","journal-title":"Digestion"},{"key":"2674_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/bja\/aep322","volume":"103","author":"P Forget","year":"2009","unstructured":"Forget P, Wittebole X, Laterre P-F (2009) Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases. Br J Anaesth 103:899\u2013900","journal-title":"Br J Anaesth"},{"key":"2674_CR21","doi-asserted-by":"publisher","first-page":"c6764","DOI":"10.1136\/bmj.c6764","volume":"341","author":"LC Claridge","year":"2010","unstructured":"Claridge LC, Eksteen B, Smith A, Shah T, Holt AP (2010) Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults. BMJ 341:c6764","journal-title":"BMJ"},{"key":"2674_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jama.296.1.87","volume":"296","author":"PB Watkins","year":"2006","unstructured":"Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC (2006) Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296:87\u201393","journal-title":"JAMA"},{"key":"2674_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2050-6511-15-39","volume":"15","author":"K Heard","year":"2014","unstructured":"Heard K, Green JL, Anderson V, Bucher-Bartelson B, Dart RC (2014) A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacol Toxicol 15:39","journal-title":"BMC Pharmacol Toxicol"},{"key":"2674_CR24","unstructured":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9 (ANAES) (2000) Evaluation et prise en charge th\u00e9rapeutique de la douleur chez les personnes \u00e2g\u00e9es ayant des troubles de la communication verbale - https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/Douleur_sujet_age_Recos.pdf"},{"key":"2674_CR25","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2007) Surveillance des malades atteints de cirrhose non compliqu\u00e9e et pr\u00e9vention primaire des complications - Recommandations - https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/surveillance_cirrhose_-_recommandations_2008_02_13__17_41_31_104.pdf"},{"key":"2674_CR26","volume-title":"Recommandations apr\u00e8s le retrait des associations dextropropoxyph\u00e8ne\/parac\u00e9tamol et dextropropoxyph\u00e8ne\/parac\u00e9tamol\/caf\u00e9ine","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (AFSSAPS)","year":"2011","unstructured":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (AFSSAPS) (2011) Prise en charge des douleurs de l\u2019adulte mod\u00e9r\u00e9es \u00e0 intenses. In: Recommandations apr\u00e8s le retrait des associations dextropropoxyph\u00e8ne\/parac\u00e9tamol et dextropropoxyph\u00e8ne\/parac\u00e9tamol\/caf\u00e9ine"},{"key":"2674_CR27","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.revmed.2010.08.001","volume":"31","author":"E Arques-Armoiry","year":"2010","unstructured":"Arques-Armoiry E, Cabelguenne D, Stamm C, Janoly-Dumenil A, Grosset-Grange I, Vantard N, Maire P, Charpiat B (2010) Most frequent drug-related events detected by pharmacists during prescription analysis in a university hospital. Rev Med Interne 31:804\u2013811","journal-title":"Rev Med Interne"},{"key":"2674_CR28","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/2013.jamainternmed.438","volume":"172","author":"L Zhou","year":"2012","unstructured":"Zhou L, Maviglia SM, Mahoney LM, Chang F, Orav EJ, Plasek J, Boulware LJ, Lou H, Bates DW, Rocha RA (2012) Supratherapeutic dosing of acetaminophen among hospitalized patients. Arch Intern Med 172:1721\u20131728","journal-title":"Arch Intern Med"},{"key":"2674_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pharma.2012.05.002","volume":"70","author":"B Charpiat","year":"2012","unstructured":"Charpiat B, Henry A, Leboucher G, Tod M, Allenet B (2012) Overdosed prescription of paracetamol (acetaminophen) in a teaching hospital. Ann Pharm Fr 70:213\u2013218","journal-title":"Ann Pharm Fr"},{"key":"2674_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.pharma.2016.03.004","volume":"74","author":"F Viguier","year":"2016","unstructured":"Viguier F, Roessle C, Zerhouni L, Rouleau A, Benmelouka C, Chevallier A, Chast F, Conort O (2016) Clinical pharmacist influence at hospital to prevent overdosed prescription of acetaminophen. Ann Pharm Fr 74:482\u2013488","journal-title":"Ann Pharm Fr"},{"key":"2674_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.therap.2017.01.007","volume":"72","author":"J-B Pace","year":"2017","unstructured":"Pace J-B, Nave V, Moulis M, Bourdelin M, Coursier S, Jean-Bart \u00c9, Leroy B, Bonnefous JL, Bontemps H, Coutet J, Eyssette C, Pont E (2017) Prescription of acetaminophen in five French hospitals: what are the practices? Therapie 72:579\u2013586","journal-title":"Therapie"},{"key":"2674_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/ageing\/19.6.419","volume":"19","author":"HA Wynne","year":"1990","unstructured":"Wynne HA, Cope LH, Herd B et al (1990) The association of age and frailty with paracetamol conjugation in man. Age Ageing 19:419\u2013424","journal-title":"Age Ageing"},{"key":"2674_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2710.2010.01193.x","volume":"36","author":"SJ Mitchell","year":"2011","unstructured":"Mitchell SJ, Hilmer SN, Murnion BP, Matthews S (2011) Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty. J Clin Pharm Ther 36:327\u2013335","journal-title":"J Clin Pharm Ther"},{"key":"2674_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2165\/11537240-000000000-00000","volume":"50","author":"A Liukas","year":"2011","unstructured":"Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Niemi M, Neuvonen PJ, Olkkola KT (2011) Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet 50:121\u2013129","journal-title":"Clin Pharmacokinet"},{"key":"2674_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/08830185.2014.889129","volume":"33","author":"J Yan","year":"2014","unstructured":"Yan J, Li S, Li S (2014) The role of the liver in sepsis. Int Rev Immunol 33:498\u2013510","journal-title":"Int Rev Immunol"},{"key":"2674_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.gtc.2017.01.012","volume":"46","author":"AK Koehne de Gonzalez","year":"2017","unstructured":"Koehne de Gonzalez AK, Lefkowitch JH (2017) Heart disease and the liver: Pathologic Evaluation. Gastroenterol Clin North Am 46:421\u2013435","journal-title":"Gastroenterol Clin North Am"},{"key":"2674_CR37","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9 (ANSM) (2018) Th\u00e9saurus des interactions m\u00e9dicamenteuses - mise \u00e0 jour mars 2018"},{"key":"2674_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","volume":"89","author":"MD Leise","year":"2014","unstructured":"Leise MD, Poterucha JJ, Talwalkar JA (2014) Drug-induced liver injury. Mayo Clin Proc 89:95\u2013106","journal-title":"Mayo Clin Proc"},{"key":"2674_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","volume":"139","author":"K Fisher","year":"2015","unstructured":"Fisher K, Vuppalanchi R, Saxena R (2015) Drug-induced liver injury. Arch Pathol Lab Med 139:876\u2013887","journal-title":"Arch Pathol Lab Med"},{"key":"2674_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/00002018-200730060-00002","volume":"30","author":"LC Hawkins","year":"2007","unstructured":"Hawkins LC, Edwards JN, Dargan PI (2007) Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf 30:465\u2013479","journal-title":"Drug Saf"},{"key":"2674_CR41","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/15563650903232345","volume":"47","author":"EP Krenzelok","year":"2009","unstructured":"Krenzelok EP (2009) The FDA Acetaminophen Advisory Committee meeting - what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila) 47:784\u2013789","journal-title":"Clin Toxicol (Phila)"},{"key":"2674_CR42","unstructured":"Federal Drug Agency (FDA) Prescription drug products containing acetaminophen: actions to reduce liver injury from unintentional overdose. Notice Document. https:\/\/www.regulations.gov\/document?D=FDA-2011-N-0021-0001. Accessed 10 Sep 2018"},{"key":"2674_CR43","unstructured":"Federal Drug Agency (FDA) FDA Drug Safety Communication:[1-13-2011] prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm239821.htm. Accessed 10 Sep 2018"},{"key":"2674_CR44","unstructured":"Parac\u00e9tamol : l\u2019ANSM lance une consultation publique pour sensibiliser les patients et les professionnels de sant\u00e9 au risque de toxicit\u00e9 pour le foie en cas de m\u00e9susage - Point d\u2019Information - ANSM : Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Paracetamol-l-ANSM-lance-une-consultation-publique-pour-sensibiliser-les-patients-et-les-professionnels-de-sante-au-risque-de-toxicite-pour-le-foie-en-cas-de-mesusage-Point-d-Information. Accessed 10 Sep 2018"},{"key":"2674_CR45","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - Parac\u00e9tamol Teva 1g, comprim\u00e9. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0291484.htm. Accessed 10 Sept 2018"},{"key":"2674_CR46","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - Parac\u00e9tamol Cod\u00e9ine EG 500 mg\/ 30 mg, comprim\u00e9 effervescent s\u00e9cable. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0286140.htm. Accessed 10 Sept 2018"},{"key":"2674_CR47","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - Parac\u00e9tamol Zydus 500 mg, g\u00e9lule. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/frames.php?specid=67445776&typedoc=R&ref=R0230023.htm. Accessed 10 Sept 2018"},{"key":"2674_CR48","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - Parac\u00e9tamol AHCL 1g, comprim\u00e9 effervescent. (page consult\u00e9e le 17\/01\/2019). http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/frames.php?specid=61754805&typedoc=R&ref=R0328124.htm. Accessed 17 Jan 2019"},{"key":"2674_CR49","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - Doliprane 100 mg, comprim\u00e9. (page consult\u00e9e le 17\/01\/2019). http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/frames.php?specid=60234100&typedoc=R&ref=R0301400.htm. Accessed 17 Jan 2019"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-019-02674-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:49:36Z","timestamp":1781574576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-019-02674-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02674-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data was collected in accordance with the French legislation on retrospective clinical studies, in accordance with the precepts established by the Helsinki declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}